Beyond Headline Numbers: A 3-Axis Framework for Reading Big Pharma Mega Deals (Investor Lens)
When investors follow big pharma transactions, it is tempting to focus on headline numbers: total deal value, takeover premium, “multi-billion” labels. When investors follow big pharma transactions, it is tempting to focus on headline nu...
